Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

• Autors principals: Ernesto Rossi (Autor), Ilaria Grazia Zizzari (Autor), Alessandra Di Filippo (Autor), Anna Acampora (Autor), Monica Maria Pagliara (Autor), Maria Grazia Sammarco (Autor), Maurizio Simmaco (Autor), Luana Lionetto (Autor), Andrea Botticelli (Autor), Emilio Bria (Autor), Paolo Marchetti (Autor), Maria Antonietta Blasi (Autor), Giampaolo Tortora (Autor), Giovanni Schinzari (Autor), Marianna Nuti (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2022-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is commonly employed, despite the low activity, considering the lack of other effective systemic treatments. In this study, the prognostic and predictive role of soluble immune checkpoints and inflammatory cytokines/chemoki...